VL
Vishal Lodha
About Vishal Lodha
Data last updated:
Vishal Lodha has 9 years in corporate governance. Holds Managing Director and Additional Director roles. Currently with 2 companies, including Enrx Private Limited and Tekna Plasma India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Enrx Private Limited at ₹174 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 26 Sep 2017 | 1991 | ₹174 Cr (FY 2025) | Active | |
| Additional Director | 18 Oct 2024 | 2016 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vishal Lodha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vishal Lodha
Vishal Lodha has 9 years in corporate governance. Holds Managing Director and Additional Director roles. Currently with 2 companies, including Enrx Private Limited and Tekna Plasma India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Enrx Private Limited at ₹174 Cr (FY 2025).
Vishal Lodha is associated with 2 companies as Managing Director and Additional Director, including Enrx Private Limited (₹174 Cr), Tekna Plasma India Private Limited.
Vishal Lodha has expertise in General Business.
Vishal Lodha has 9 years in corporate governance.
By reported revenue, the largest current company of Vishal Lodha is Enrx Private Limited, with revenue of ₹174 Cr (FY 2025).
Vishal Lodha currently holds positions at 2 companies: Enrx Private Limited (₹174 Cr), Tekna Plasma India Private Limited.